180 Life Sciences [ATNF] vs Regeneron [REGN] Detailed Stock Comparison

180 Life Sciences

NASDAQ

Regeneron

NASDAQ

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: 180 Life Sciences wins in 4 metrics, Regeneron wins in 11 metrics, with 0 ties. Regeneron appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	180 Life Sciences	Regeneron	Better
P/E Ratio (TTM)	0.11	14.95	180 Life Sciences
Price-to-Book Ratio	7.90	2.06	Regeneron
Debt-to-Equity Ratio	26.25	9.04	Regeneron
PEG Ratio	0.00	13.09	180 Life Sciences
EV/EBITDA	-6.81	12.21	180 Life Sciences
Profit Margin (TTM)	0.00%	31.37%	Regeneron
Operating Margin (TTM)	0.00%	29.64%	Regeneron
EBITDA Margin (TTM)	N/A	29.64%	N/A
Return on Equity	-371.02%	15.34%	Regeneron
Return on Assets (TTM)	-55.46%	6.66%	Regeneron
Free Cash Flow (TTM)	$-1.48M	$3.54B	Regeneron
Dividend Yield	N/A	0.46%	N/A
1-Year Return	155.12%	-50.12%	180 Life Sciences
Price-to-Sales Ratio (TTM)	N/A	4.42	N/A
Enterprise Value	$43.94M	$54.52B	Regeneron
EV/Revenue Ratio	N/A	3.84	N/A
Gross Profit Margin (TTM)	N/A	85.58%	N/A
Revenue per Share (TTM)	$0	$133	Regeneron
Earnings per Share (Diluted)	$-14.95	$39.68	Regeneron
Beta (Stock Volatility)	0.41	0.33	Regeneron

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

180 Life Sciences vs Regeneron Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
180 Life Sciences	-8.03%	-36.79%	71.17%	358.10%	284.80%	179.65%
Regeneron	1.21%	5.69%	9.65%	-1.07%	-14.59%	-16.36%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
180 Life Sciences	155.12%	-98.40%	-99.87%	-99.86%	-99.86%	-99.86%
Regeneron	-50.12%	0.33%	-0.74%	11.45%	2,525.81%	7,886.11%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

180 Life Sciences (ATNF): View Full Stock Overview

Regeneron (REGN): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: 180 Life Sciences vs Regeneron

Metric	ATNF	REGN
Market Information
Market Cap i	$1.08B	$62.88B
Market Cap Category	Small cap	Large cap
10 Day Avg. Volume i	37,591,630	859,422
90 Day Avg. Volume i	17,141,703	933,271
Last Close	$4.81	$598.16
52 Week Range	$0.66 - $17.75	$476.49 - $1,211.20
% from 52W High	-72.90%	-50.61%
All-Time High	$4,957.10 (Apr 12, 2021)	$1,211.20 (Aug 26, 2024)
% from All-Time High	-99.90%	-50.61%
Growth Metrics
Quarterly Revenue Growth	N/A	0.04%
Quarterly Earnings Growth	N/A	-0.03%
Financial Health
Profit Margin (TTM) i	0.00%	0.31%
Operating Margin (TTM) i	0.00%	0.30%
Return on Equity (TTM) i	-3.71%	0.15%
Debt to Equity (MRQ) i	26.25	9.04
Cash & Liquidity
Book Value per Share (MRQ)	$0.89	$287.55
Cash per Share (MRQ)	$0.37	$72.04
Operating Cash Flow (TTM) i	$-3,159,107	$4.74B
Levered Free Cash Flow (TTM) i	$-3,003,669	$2.85B
Dividends
Last 12-Month Dividend Yield i	N/A	0.46%
Last 12-Month Dividend i	N/A	$2.64

Valuation & Enterprise Metrics Analysis: 180 Life Sciences vs Regeneron

Metric	ATNF	REGN
Price Ratios
P/E Ratio (TTM) i	0.11	14.95
Forward P/E i	-15.30	13.09
PEG Ratio i	0.00	13.09
Price to Sales (TTM) i	N/A	4.42
Price to Book (MRQ) i	7.90	2.06
Market Capitalization
Market Capitalization i	$1.08B	$62.88B
Enterprise Value i	$43.94M	$54.52B
Enterprise Value Metrics
Enterprise to Revenue i	N/A	3.84
Enterprise to EBITDA i	-6.81	12.21
Risk & Other Metrics
Beta i	0.41	0.33
Book Value per Share (MRQ) i	$0.89	$287.55

Financial Statements Comparison: 180 Life Sciences vs Regeneron

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	ATNF	REGN
Revenue/Sales i	$0	$3.03B
Cost of Goods Sold i	N/A	$464.30M
Gross Profit i	N/A	$2.56B
Research & Development i	$322,758	$1.34B
Operating Income (EBIT) i	$-1.73M	$591.70M
EBITDA i	$-1.72M	$900.90M
Pre-Tax Income i	$-1.73M	$905.00M
Income Tax i	$0	$96.30M
Net Income (Profit) i	$-1.73M	$808.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	ATNF	REGN
Cash & Equivalents i	$3.72M	$3.09B
Total Current Assets i	$4.03M	$17.57B
Total Current Liabilities i	$3.94M	$3.57B
Long-Term Debt i	$3,425	$2.70B
Total Shareholders Equity i	$7.71M	$29.39B
Retained Earnings i	$-143.89M	$32.38B
Property, Plant & Equipment i	N/A	N/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	ATNF	REGN
Operating Cash Flow i	$-1.45M	$1.36B
Capital Expenditures i	N/A	N/A
Free Cash Flow i	$-853,723	$773.60M
Debt Repayment i	$-3,320	N/A
Common Stock Repurchase i	N/A	$-1.05B

Short Interest & Institutional Ownership Analysis

Metric	ATNF	REGN
Shares Short i	1.14M	2.29M
Short Ratio i	0.19	2.55
Short % of Float i	0.47%	0.02%
Average Daily Volume (10 Day) i	37,591,630	859,422
Average Daily Volume (90 Day) i	17,141,703	933,271
Shares Outstanding i	3.18M	109.62M
Float Shares i	5.04M	97.89M
% Held by Insiders i	0.10%	0.02%
% Held by Institutions i	0.00%	0.91%

Dividend Analysis & Yield Comparison: 180 Life Sciences vs Regeneron

Metric	ATNF	REGN
Last 12-Month Dividend i	N/A	$2.64
Last 12-Month Dividend Yield i	N/A	0.46%
3-Year Avg Annual Dividend i	N/A	$0.88
3-Year Avg Dividend Yield i	N/A	0.14%
3-Year Total Dividends i	N/A	$2.64
Ex-Dividend Date	N/A	Aug 18, 2025

180 Life Sciences [ATNF] vs Regeneron [REGN] Detailed Stock Comparison